Bicarbonate administration has been shown to control Yumm1.1 melanoma growth and increase CD8+ T cell infiltration and NK and B cell activation, as well as improve anti-CTLA4 and anti–PD-1 therapy and adoptive cell therapy, in B16 melanoma–bearing mice (125, 126). This evidence concerns the gene CTLA4 and melanoma.